XSTO
ARCOMA
Market cap11mUSD
Oct 09, Last price
7.56SEK
1D
0.79%
1Q
-8.98%
Jan 2017
104.24%
IPO
-34.02%
Name
Arcoma AB
Chart & performance
P/E
21.51
P/S
0.83
EPS
0.35
Div yield, %
—
Shrs. gr., 5y
2.37%
Rev. gr., 5y
2.18%
Revenues
131m
-16.59%
Net income
5m
-55.00%
CFO
19m
-0.66%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.
Key people
Lars Kvarnhem
Chairman of the Board · since 2017
Mattias Leire
Chief Executive Officer · since 2023
Johan Dahlberg
Chief Financial Officer · since 2022
Henrik Blomdahl
Quality Manager · since 2021
Nicklas Johansson
Production Manager · since 2019
Jesper Lindroos
Purchasing Manager · since 2020
Linda Ungsten
Product Manager · since 2011
Jean-Yves Burel
Director · since 2015
Director · since 2010
Director · since 2022
Headquarters & legal address
Annavägen 1
Växjö, G 352 46
SE
Växjö, G 352 46
SE
Address
Annavagen 1
Vaxjo, G 352 46
SE
Vaxjo, G 352 46
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||